comprehensive -WSS

comprehensive

author：hotspot 2025-09-02 11:43:45 - browse：33

Neumora, a privately held biotech company, is moving into the final phase of testing with a novel treatment for depression that showed promise in a mid-stage trial.

The drug, a daily pill called navacaprant, led to statistically significant improvements over placebo on a measurement of disease severity for patients with moderate to severe major depressive disorder, Neumora said Tuesday. In the eight-week study, the medicine also led to improvements in patient-reported anhedonia, a reduced ability to experience pleasure that often accompanies severe depression.

Navacaprant’s statistically significant benefits came from a pre-specified subset of 100 patients in a study that enrolled 171 people. In the total population, including 71 patients who had mild to moderate disease, navacaprant’s effect on depressive symptoms was numerically superior to placebo but did not reach the threshold of statistical significance, missing the study’s primary endpoint.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Will General Catalyst be the first of many hospital takeovers?

entertainment

WSS

Medicare will require more price transparency from hospitals

Alabama frozen embryo ruling has major implications for IVF clinics

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

explore

comprehensive

focus

Alkermes shareholders re

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Continuity nursing helped my family in our darkest PICU moments

Alabama frozen embryo ruling has major implications for IVF clinics

The high cost of giving birth even with insurance

Medicare solvency divides Republicans at the presidential debate

At least 13 dead in Texas as scorching temps continue

Antivenom research: Lessons from HIV applied in search for universal antidote

Malaria cases in Florida and Texas: Here’s what you need to know

Ambulance rides for just $100? Advisers want major billing fixes

entertainment

Dario to buy mental health app maker Twill in cash and stock deal

MoonLake credibility takes another hit with mid

The Harvard botanist who searched for psychedelics in the Amazon

Medicare will require more price transparency from hospitals

Dario to buy mental health app maker Twill in cash and stock deal

Sanofi CEO defends move to abandon profit guidance, boost research

leisure time

hotspot

entertainment

Wikipedia